Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antineoplastic/antifungal agent revealed

June 28, 1996

MT-332: Pharma Mar's novel cytotoxic metabolite

June 28, 1996

Antitumor epidioxymanadic acid described by Pharma Mar

June 28, 1996

Marimastat enters U.S. and U.K. phase III trial

June 28, 1996

Therapeutic melanoma vaccine in phase I

June 28, 1996

Eulexin is FDA-approved for new indication

June 28, 1996

More antitumor taxoids

June 28, 1996

LHRH antagonists from TAP Holdings

June 28, 1996

Antitumor taxoids revealed

June 28, 1996

DepoCyt earns positive phase III results

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...